ApoE−/− mice receiving WD showed abnormal glucose tolerance, hepatomegaly, weight gain and full spectrum of NASH including hepatic steatosis, fibrosis and inflammation, with no sign of renal damage. This evidence concerns the gene APOE and metabolic dysfunction-associated steatohepatitis.